[HTML][HTML] Generating natural killer cells for adoptive transfer: expanding horizons

S Kundu, M Gurney, M O'Dwyer - Cytotherapy, 2021 - Elsevier
Natural killer (NK) cells are unique innate lymphoid cells that have therapeutic potential in
adoptive cell transfer-based cancer immunotherapy that has been established across a …

[HTML][HTML] Manufacturing CAR-NK against tumors: Who is the ideal supplier?

F Guo, Y Zhang, J Cui - Chinese Journal of Cancer Research, 2024 - ncbi.nlm.nih.gov
Chimeric antigen receptor-natural killer (CAR-NK) cells have emerged as another prominent
player in the realm of tumor immunotherapy following CAR-T cells. The unique features of …

Development of a scalable and robust upstream process for the chemically-defined production of lentiviral vectors for gene-modified cellular immunotherapies

C Ripoll Fiol - 2024 - discovery.ucl.ac.uk
Ex vivo gene-modified cellular immunotherapy, including chimeric antigen receptor (CAR)-T
and CAR-NK cell therapy, is a promising therapeutic modality for the treatment of various …